Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)

TOPICS

  • Topics
  • Results
  • Acknowledgement
2023.09.04

A site visit to support the promotion of startup creation/growth under the Co-Creation Opportunity Formation Support Program (COI-NEXT) was held, where advice was given by members of the Startup Support Promotion Committee and a lively exchange of opinions took place.
Number of participants: 37 (on-site: 17, online: 20)

site visit

2023.08.30

The COI-NEXT (Co-Creation Opportunity Formation Support Program) Policy Focus Area (Full-Scale) Site Visit was held, where the PO, Deputy PO, AD, and MEXT staff gave advice and engaged in a lively exchange of opinions.
Participating companies were also invited to attend.
    Number of participants: 82 (on-site: 57, online: 25)

site visit

2023.07.25
The 10th Steering Committee meeting was held and progress was shared with all members.
2023.06.28 - 30
Participated in the 75th Annual Meeting of the Japanese Society for Cell Biology to promote the KENTO Imaging Support Center.
2023.05.09
Moonshot Webinar "Introduction of Shared Equipment at Kento Imaging Support Center" was held and attended by 58 people.
2023.04.05
The 9th Steering Committee meeting was held and progress was shared with all members.
2023.03.09
The Raman microscopy seminar was held and attended by 72 people, including online participation.
【演者】
Katsushige Fujita (Osaka University, Graduate School of Engineering)
Takeshi Minamikawa (Post-LED Photonics Laboratory, The University of Tokushima)
Taisuki Koseki (Graduate School of Engineering, University of Tokyo)
2023.01.12
The 8th Steering Committee meeting was held and progress was shared with all members. In addition, the General Foundation for Research on Microbial Diseases of Osaka University, Osaka Public University, and Wellier Corporation were approved as new participating institutions.
2022.11.25
JST's FY2022 "Startup Creation/Growth Promotion Support" program has been adopted.
(Amount of support: up to 100 million yen, period: up to 3 years)
2022.09.07
The Kick-off Symposium for the Kento Imaging Support Center was held and attended by 102 people including from companies and universities
[ presenter ]
Keisuke Ota (Professor, Center for Advanced Imaging Research, Kurume University School of Medicine)
Yasushi Okada (Professor, Graduate School of Medicine, The University of Tokyo)
Li-Kun Phng (Team Leader, RIKEN Center for Frontier Biosciences)
Atsushi Miyawaki (Team Leader, RIKEN Neuroscience Research Center and Photonics Research Center)
Yu Ishii (Professor, Graduate School of Medicine, Osaka University)
2022.08.30
Official transition to full-scale support by JST has been approved.
(Amount of support: up to about 400 million yen/year, until FY2029)
We would like to thank all participating institutions for their cooperation and guidance over the past two years.
We look forward to your continued support.
2022.08.10
The registration site for the Kick-off Symposium of Kento Imaging Support Center on September 7 has been released.
2022.07.06
The 6th Steering Committee meeting was held to report progress to all members.
2022.06.24
The site visit was conducted as a transitional evaluation (second- phase evaluation) to full-scale support by JST.
2022.05.18
Kowa Corporation, a participating organization in the Health and Medical Data Platform, has pre-released a health promotion support [Suita Self-Care Suite Trial].
2022.10.25
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
A high WBC count can predict atrial fibrillation: The Suita Study.
2022.08.24
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Serum uric acid levels associated with risk of diabetes mellitus in peri- and postmenopausal women living in urban areas.
2022.08.17
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Association of liver enzymes and alcohol intake with risk of developing diabetes mellitus among urban area residents.
2022.07.25
Research and Development Project 6 Leader Yoshihiro Kokubo, Specially Appointed Director, has published on the Health Checkup Department WEB site.
Evidence from Japan of 10 items of lifelong health support to be used in the new health guidance of the Heart Failure Severe Prevention Project
2022.03.04
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Stair climbing and incident atrial fibrillation: a prospective cohort study
2022.01.26
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Mild Hypertensive Retinopathy and Risk of Cardiovascular Disease: The Suita Study
2021.12.08
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Developing a Stroke Risk Prediction Model Using Cardiovascular Risk Factors: The Suita Study --Stroke Risk in Urban Population. Cerebrovascular Diseases. 2021.

When research related to this program or research using the equipment installed in the "Kento Imaging Support Center" is published in a paper, it will be introduced on the website of the Place for Co-Creation and reported to JST as an achievement.

[ Research related to this program ]
Please indicate your grant number below.
Grant number of the Co-Creation Field: JPMJPF2018
When your paper is accepted, please inform the Co-Creation Field Support Office.
We will publish your paper as a result on the website of Place for Co-Creation.

( For inquiries, please contact )
National Cerebral and Cardiovascular Center
Open Innovation Center, Industry-Academia Collaboration Division
6-1 Kishibe Shinmachi, Suita City, Osaka, Japan
E-mail: coi-next-so@ml.ncvc.go.jp
TEL: 06-6170-1070

List of TOPICS >

  • Northern Osaka Health and Biomedical Innovation Town KENTO
  • National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)
  • National University Corporation Tokushima University
  • Eisai Co., Ltd.
  • KAN Research Institute, Inc.
  • Towa Pharmaceutical Co., Ltd.
  • Sysmex Corporation
  • Nipro Corporation
  • JSR Corporation
  • CYBERDYNE, Inc.
  • crossEffect, Inc.
  • CMIC HOLDINGS Co., Ltd.
  • Osaka Chamber of Commerce and Industry
  • Osaka Prefectural Government
  • Suita City
  • Settsu City
  • LSI Medience Corporation
  • Mizuho Bank, Ltd.
  • Kobe University
  • AIR WATER INC.
  • Kowa Company, Ltd.
  • JSPA(Japan Selfcare Promotion Association)
  • The SC approved MUFG Bank
  • Hankyu Hanshin Holdings Co., Ltd.
  • JCR Pharma Co., Ltd.
  • NEXGEN Co., Ltd.
  • Kyoto University
  • Osaka University
  • Shiga University of Medical Science
  • Kobe Pharmaceutical University
  • Osaka Metropolitan University
  • The Research Foundation for Microbial Diseases of Osaka University
  • Wellier Corporation
  • General Incorporated Association KENTO Co-Creation Promotion Organization (KCOP)